Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target
Y. Gao, L. Yan, Y. Huang, F. Liu, Y. Zhao, L. Cao, T. Wang, Q. Sun, Z. Ming, L. Zhang, J. Ge, L. Zheng, Y. Zhang, H. Wang, Y. Zhu, C. Zhu, T. Hu, T. Hua, B. Zhang, X. Yang, J. Li, H. Yang, Z. Liu, W. Xu, L. W. Guddat, , Z. Rao
Abstract
A novel coronavirus (2019-nCoV) outbreak has caused a global pandemic resulting in tens of thousands of infections and thousands of deaths worldwide. The RNA-dependent RNA polymerase (RdRp, also named nsp12), which catalyzes the synthesis of viral RNA, is a key component of coronaviral replication/transcription machinery and appears to be a primary target for the antiviral drug, remdesivir. Here we report the cryo-EM structure of 2019-nCoV full-length nsp12 in complex with cofactors nsp7 and nsp8 at a resolution of 2.9-[A]. Additional to the conserved architecture of the polymerase core of the viral polymerase family and a nidovirus RdRp-associated nucleotidyltransferase (NiRAN) domain featured in coronaviral RdRp, nsp12 possesses a newly identified {beta}-hairpin domain at its N-terminal. Key residues for viral replication and transcription are observed. A comparative analysis to show how remdesivir binds to this polymerase is also provided. This structure provides insight into the central component of coronaviral replication/transcription machinery and sheds light on the design of new antiviral therapeutics targeting viral RdRp. One Sentence SummaryStructure of 2019-nCov RNA polymerase.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structure of replicating SARS-CoV-2 polymerase
H. S. Hillen, G. Kokic, … P. Cramer·bioRxiv·Apr 27, 2020
- Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir
Wanchao Yin, Chunyou Mao, … H. Eric Xu·SciencePeer-reviewed·May 1, 2020
- Remdesivir is a delayed translocation inhibitor of SARS CoV-2 replication in vitro
J. P. Bravo, T. L. Dangerfield, … K. A. Johnson·bioRxiv·Dec 14, 2020
- A dynamic regulatory interface on SARS-CoV-2 RNA polymerase
Wei Kang Shi, Ming Chen, … Bin Liu·bioRxiv·Jul 30, 2020
- Structure of the SARS-CoV NSP12 polymerase bound to NSP7 and NSP8 co-factors
R. N. Kirchdoerfer, A. B. Ward·bioRxiv·Feb 15, 2019
- Structural basis for repurpose and design of nucleoside drugs for treating COVID-19